CANADA

Canadian Thoracic Society
CTS Info
rmation and Guidance for Respiratory Health Care Professionals on COVID-19 Vaccination (archived)
Please follow the latest updates from Government of Canada on COVID-19 vaccineCanadian Immunization Guide for Health Care Professionals
CTS-AMMI Canada joint statement promoting dual vaccination against influenza and COVID-19
CTS-CSACI: Biologic Therapy and the COVID-19 vaccine – Advice for individuals with asthma
AJRCCM article re: Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma

YouTube: https://www.youtube.com/channel/UCDlMND24SJwt4N_o2g5bIoA
Follow on Twitter: https://twitter.com/TheFeedWithDrG
Like on Facebook: https://www.facebook.com/TheFeedWithDrG/


Respiratory Roundtable Joint Statement on the prioritization of Canadians with lung disease in COVID-19 vaccination rollout

AMMI Canada Educational Webinars on COVID-19 vaccines

Canadian Institutes of Health Research (CIHR) Presentations:
Long COVID: Emerging Research and Gaps in Canada
GLOPID-R – Long Covid
State of Knowledge, Emerging Research Needs & Canadian Research Landscape for Post-COVID-19 conditions
Recommended Resources

Canadian Medical Association (CFPC & RCPSC)
Questions and answers on COVID-19: https://www.covidquestions.ca

Canadian Paediatric Society
COVID-19 vaccine for children 5 to 11 years of age
Clinical guidance for youth with myocarditis and pericarditis following mRNA COVID-19 Vaccination
Position Statement: COVID-19 vaccine for children

CANVAXNEW VIDEOS
Needle fear, pain and vaccines: introduction to the CARDTM system as a framework for vaccination delivery (40 minutes)
An overview of Novavax Nuvaxovid™ and Medicago Covifenz® (18 minutes)
COVID-19 Vaccine Questions and Answers for Healthcare Providers

CoVaRR-NetCoronavirus Variants Rapid Response Network (CoVaRR-Net) is a network of interdisciplinary researchers from institutions across the country created to assist in the Government of Canada’s overall strategy to address the potential threat of emerging SARS-CoV-2 variants.

National Collaborating Centre for Infectious Diseases
Recommendations of the National Advisory Committee on Immunization (NACI) on Extended Dose Intervals for COVID-19 Vaccines

COVID-19 Vaccines Planning for Immunization Clinics – March 1, 2021
COVID-19 Vaccines Foundational Webinar Feb 23, 2021

COVID-19 Vaccines – Allergies and LDV Syringe Discussion – Feb 10, 2021

MD Briefcase
Paediatric COVID-19 Update – Video
COVID-19 Vaccination in Children 5-11 Years of Age​: Practical Guidance for Discussing Risks and Benefits – Video
Encouraging COVID-19 Vaccination in Adolescents 12 Years of Age and Older – Video
One shot after the other: The importance of influenza protection in patients immunized against COVID-19 – Free Course

National Institute of Ageing
COVID-19 Visit Risk Calculator

Public Health Agency of Canada Vaccine Confidence InfoBulletin NEW
Issue 1 – January 2022
Issue 2 – February 2022
Issue 3 – March 2022
Issue 4 – April 2022
Issue 4.1 Special Edition on Boosters – April 2022
Issue 5 – May 2022
Issue 6 – June 2022

Issue 7.1 – July 2022
Issue 8 – August 2022
Issue 9 – Sept 2022
Issue 10 – Nov 2022

Infobulletin on VITT for health care providers – April 13, 2021

Respiplus
Addressing Patient Hesitancy: https://youtu.be/6OqQfuwDhTMAugust 2021

Think Research/MDBriefcase
Managing Vaccine Hesitancy – Accredited Program – March 25, 2021
Think Research launched an educational hub hosted by MDBriefcase which includes an accredited Vaccine Hesitancy program designed for primary care physicians and other supporting clinicians to help improve vaccine confidence in patients.

INTERNATIONAL